Cg Oncology, Inc. (CGON) — SC 13G Filings
All SC 13G filings from Cg Oncology, Inc.. Browse 8 Passive Stake Filing reports with AI-powered summaries and risk analysis.
SC 13G Filings (8)
- SC 13G Filing — Nov 8, 2024
- SC 13G Filing — Oct 22, 2024
- SC 13G Filing — Jul 22, 2024
- SC 13G Filing — Mar 14, 2024
-
TCG Crossover GP I Discloses 10% Stake in CG Oncology
— Feb 9, 2024 Risk: low
TCG Crossover GP I, LLC, along with its group members CHEN YU and TCG CROSSOVER FUND I, L.P., reported beneficial ownership of 5,000,000 shares of CG Oncology, -
Decheng Capital Takes 20% Stake in CG Oncology
— Feb 8, 2024 Risk: low
Decheng Capital Global Life Sciences Fund IV, L.P. (and its affiliated entities including Decheng Capital Global Healthcare Fund (Master), LP) has reported a si -
Longitude Capital Discloses 9.9% Stake in CG Oncology
— Feb 5, 2024
Longitude Capital Partners IV, LLC, a venture capital firm, reported on February 5, 2024, that it beneficially owns 4,333,333 shares of CG Oncology, Inc. (NASDA -
Foresite Capital Discloses Significant Stake in CG Oncology
— Feb 5, 2024
Foresite Capital Fund V, L.P. and its affiliated entities, including Foresite Capital Management V, LLC and Foresite Capital Fund VI, L.P., filed an SC 13G on F
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX